Arkolith/Insider Trading/EVOK/Form 4

Hill Malcolm R

DirectorEvoke Pharma Inc (EVOK) · full profile →Form 4 · filed Dec 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2025Tender(U)133——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Disposed to issuer(D)1K——0
Dec 17, 2025Disposed to issuer(D)6K——0
Dec 17, 2025Disposed to issuer(D)1K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-322642) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML